Nova LTD

Form 420-F13G

Insider Trading (Form 4)

See all →
NASDAQ
Shay Wolfing, CTO of Nova Ltd., sold 3,864 shares of common stock on September 21, 2026 for $363.28 per share.
NASDAQ
Gabriel Waisman, CEO & President of Nova Ltd., sold 1,500 shares of common stock on September 1, 2026 for $342.27 per share.
NASDAQ
Shay Wolfing, CTO of Nova Ltd., received 1,259 shares of common stock on September 1, 2026.
NASDAQ
Guy Kizner, CFO of Nova Ltd., received 1,297 shares of common stock on September 1, 2026.
NASDAQ
NOVA LTD. CEO Gabriel Waisman reports transactions involving ordinary shares and restricted share units, detailing ownership and vesting schedules.
NASDAQ
NOVA LTD. CEO Gabriel Waisman reports acquisition of 7,056 ordinary shares through vesting of performance stock units and restricted share units.

Schedule 13G - Passive Investments

See all →
NASDAQ
Phoenix Financial Ltd. and Partnership for Israeli shares have reported beneficial ownership of NOVA LTD. ordinary shares, totaling 8.64% and 5.88% respectively.
NASDAQ
FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 2,759,193 shares, representing 8.7% of Nova Ltd's common stock as of March 31, 2026.
NASDAQ
Wasatch Advisors LP filed an Amendment No. 8 to Schedule 13G, reporting a 4.6% beneficial ownership in Nova Ltd as of December 31, 2025.
NASDAQ
Harel Insurance Investments & Financial Services Ltd. has reported an increased beneficial ownership in NOVA LTD., now holding 10.6% of the ordinary shares.
NASDAQ
Migdal Insurance & Financial Holdings Ltd. and its subsidiaries have disclosed a combined beneficial ownership of 8.07% in NOVA LTD.'s Ordinary Shares.
NASDAQ
Clal Insurance Enterprises Holdings Ltd. has reported a 4.5% beneficial ownership stake in NOVA LTD. through an Amendment No. 1 to its Schedule 13G filing.
Delay expected